
ACoA: ACR Guidelines: Interstitial Lung Disease (ILD)
ACR on Air
00:00
Treatment Recommendations for ILD in Rheumatic Diseases
This chapter discusses the new recommendations for the treatment of interstitial lung disease (ILD) in people with rheumatic diseases, including the use of Nintendenib and calcineurin inhibitors. It also explores the management of rapidly progressive ILD and the considerations for lung transplant evaluation.
Transcript
Play full episode